In disagreement with this statement of Dixon et al [16], Beymer et al [17] showed that BMI did not differ between groups with and without NASH in morbidly obese patients, and that insulin resistance, hypertension, and elevated ALT were independently predicted the presence of NASH. Here, GPT is linked to metabolic dysfunction-associated steatohepatitis.